438 related articles for article (PubMed ID: 23633385)
21. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
[TBL] [Abstract][Full Text] [Related]
22. Purification process of recombinant monoclonal antibodies with mixed mode chromatography.
Maria S; Joucla G; Garbay B; Dieryck W; Lomenech AM; Santarelli X; Cabanne C
J Chromatogr A; 2015 May; 1393():57-64. PubMed ID: 25805720
[TBL] [Abstract][Full Text] [Related]
23. Designing an Autonomous Integrated Downstream Sequence From a Batch Separation Process - An Industrial Case Study.
Löfgren A; Andersson N; Sellberg A; Nilsson B; Löfgren M; Wood S
Biotechnol J; 2018 Apr; 13(4):e1700691. PubMed ID: 29247601
[TBL] [Abstract][Full Text] [Related]
24. Weak partitioning chromatography for anion exchange purification of monoclonal antibodies.
Kelley BD; Tobler SA; Brown P; Coffman JL; Godavarti R; Iskra T; Switzer M; Vunnum S
Biotechnol Bioeng; 2008 Oct; 101(3):553-66. PubMed ID: 18727127
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody purification using activated carbon as a replacement for Protein A affinity chromatography.
Ishihara T; Miyahara M; Yamamoto K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():1-7. PubMed ID: 30366207
[TBL] [Abstract][Full Text] [Related]
26. Accelerated purification process development of monoclonal antibodies for shortening time to clinic. Design and case study of chromatography processes.
Ishihara T; Kadoya T
J Chromatogr A; 2007 Dec; 1176(1-2):149-56. PubMed ID: 18035359
[TBL] [Abstract][Full Text] [Related]
27. Fragments of protein A eluted during protein A affinity chromatography.
Carter-Franklin JN; Victa C; McDonald P; Fahrner R
J Chromatogr A; 2007 Sep; 1163(1-2):105-11. PubMed ID: 17643441
[TBL] [Abstract][Full Text] [Related]
28. Real-time monitoring and control of the load phase of a protein A capture step.
Rüdt M; Brestrich N; Rolinger L; Hubbuch J
Biotechnol Bioeng; 2017 Feb; 114(2):368-373. PubMed ID: 27543789
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of viruses using novel protein A wash buffers.
Bolton GR; Selvitelli KR; Iliescu I; Cecchini DJ
Biotechnol Prog; 2015; 31(2):406-13. PubMed ID: 25482293
[TBL] [Abstract][Full Text] [Related]
30. Anion exchange chromatography provides a robust, predictable process to ensure viral safety of biotechnology products.
Strauss DM; Gorrell J; Plancarte M; Blank GS; Chen Q; Yang B
Biotechnol Bioeng; 2009 Jan; 102(1):168-75. PubMed ID: 18683259
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody capture and viral clearance by cation exchange chromatography.
Miesegaes GR; Lute S; Strauss DM; Read EK; Venkiteshwaran A; Kreuzman A; Shah R; Shamlou P; Chen D; Brorson K
Biotechnol Bioeng; 2012 Aug; 109(8):2048-58. PubMed ID: 22488719
[TBL] [Abstract][Full Text] [Related]
32. Model-based design and control of a small-scale integrated continuous end-to-end mAb platform.
Gomis-Fons J; Schwarz H; Zhang L; Andersson N; Nilsson B; Castan A; Solbrand A; Stevenson J; Chotteau V
Biotechnol Prog; 2020 Jul; 36(4):e2995. PubMed ID: 32233078
[TBL] [Abstract][Full Text] [Related]
33. Chromatographic techniques in the downstream processing of proteins in biotechnology.
Freitag R
Methods Mol Biol; 2014; 1104():419-58. PubMed ID: 24297429
[TBL] [Abstract][Full Text] [Related]
34. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
[TBL] [Abstract][Full Text] [Related]
35. DNA spike studies for demonstrating improved clearance on chromatographic media.
Butler MD; Kluck B; Bentley T
J Chromatogr A; 2009 Oct; 1216(41):6938-45. PubMed ID: 19733359
[TBL] [Abstract][Full Text] [Related]
36. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
Dizon-Maspat J; Bourret J; D'Agostini A; Li F
Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
[TBL] [Abstract][Full Text] [Related]
37. Engineering protein A affinity chromatography.
Jungbauer A; Hahn R
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):248-56. PubMed ID: 15603260
[TBL] [Abstract][Full Text] [Related]
38. Innovative next-generation monoclonal antibody purification using activated carbon: A challenge for flow-through and column-free processes.
Ishihara T; Miyahara M; Yamada T; Yamamoto K
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():72-81. PubMed ID: 31128526
[TBL] [Abstract][Full Text] [Related]
39. An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.
Andrade C; Arnold L; Motabar D; Aspelund M; Tang A; Hunter A; Chung WK
Biotechnol Prog; 2019 Jan; 35(1):e2720. PubMed ID: 30298991
[TBL] [Abstract][Full Text] [Related]
40. Complete or periodic continuity in continuous manufacturing platforms for production of monoclonal antibodies?
Kateja N; Tiwari A; Thakur G; Rathore AS
Biotechnol J; 2021 Jul; 16(7):e2000524. PubMed ID: 33773062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
